Possible augmentation of warfarin effect by glucosamine-chondroitin.
Vitalina
V
Rozenfeld
Judy L
JL
Crain
A Kevin
AK
Callahan
D000368:Aged; D000818:Animals; D001281:Atrial Fibrillation / Q000188:drug therapy; D002809:Chondroitin Sulfates / Q000008:administration & dosage / Q000009:adverse effects*; D002908:Chronic Disease; D000075202:Contraindications; D004338:Drug Combinations; D004347:Drug Interactions; D004357:Drug Synergism; D005944:Glucosamine / Q000008:administration & dosage / Q000009:adverse effects*; D006801:Humans; D019934:International Normalized Ratio; D017895:Manganese Compounds / Q000008:administration & dosage / Q000009:adverse effects; D012651:Self Medication; D013431:Sulfates / Q000008:administration & dosage / Q000009:adverse effects; D014859:Warfarin / Q000008:administration & dosage / Q000627:therapeutic use*
D004338:Drug Combinations; D017895:Manganese Compounds; D013431:Sulfates; D014859:Warfarin; D002809:Chondroitin Sulfates; D005944:Glucosamine; C039798:manganese sulfate